Analysis on the clinical features of 22 basaloid squamous cell carcinoma of the lung.
BACKGROUND
Basaloid squamous cell carcinoma of the lung is a rare and highly malignant tumor mostly observed in the proximal bronchi. Basaloid squamous cell carcinoma of the lung cases typically show rapid clinical progression, very poor prognosis and special pathological morphology. This project aimed to examine the clinical features of basaloid squamous cell carcinoma of the lung and the factors related to its prognosis; and to compare survival outcomes between basaloid squamous cell carcinoma and poorly differentiated squamous cell carcinomas (PDSC).


METHODS
Between January 2004 and December 2008, pathological sections from basaloid squamous cell carcinoma and PDSC of the lung were collected and retrospectively analyzed at Tianjin Medical University Cancer Institute and Hospital. Data analysis was performed using Statistical Package for the Social Sciences (SPSS11.0). The Kaplan-Meier method was used to calculate the survival rate. Log-rank test was used to compare the differences in survival rate between the two groups. The factors influencing prognosis were analyzed using the Cox proportional hazard model.


RESULTS
A total of 120 pathological sections were used in the analysis of this study-22 from basaloid squamous cell carcinoma cases and 98 from PDSC cases. Compared to the PDSC group, the basaloid squamous cell carcinoma group had a larger proportion of female patients (p = 0.001); however it had higher proportion of male smokers (p = 0.003). There were no statistically significant differences in survival rate between the two groups (χ2 = 1.200, p = 0.273). Additionally, prognosis of basaloid squamous cell carcinoma is significantly influenced by treatment mode and clinical stages of the tumor. The post-operation mortality hazard of patients treated with a combination chemotherapy and radiotherapy was 1.296 times higher than other treatment modes (p = 0.025). Increases in post-operation mortality hazard ratio were also associated with more advanced clinical stage of tumors (χ2 trend = 11.907, p = 0.000).


CONCLUSIONS
This study demonstrated that basaloid squamous cell carcinoma and PDSC have very similar clinical features, and there are no significant differences in survival rates between the two groups. Hence, we conclude that in the short term, the same clinical treatments and therapeutic modes can be administered to patients with basaloid squamous cell carcinoma and PDSC of the lung.
Department of Thoracic Surgery, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, PR China.
Li C
LC
Wang
Lei
L
Wang
Sabrina
S
Kwauk
Jennifer A
JA
Woo
Li Q
LQ
Wu
Hong
H
Zhu
Li Z
LZ
Zhan
Na L
NL
Sun
Lei
L
Zhang
D002280:Basal Cell Carcinoma / Q000401:mortality / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology*; D002681:China / Q000453:epidemiology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends
Hum Pathol. 1992 Sep;23(9):993-1003
1381335
Ann Thorac Surg. 2003 Dec;76(6):1833-7
14667594
Pathol Int. 2005 Jul;55(7):445-52
15982222
Eur Respir J. 2008 Apr;31(4):854-9
18094005
Pathology. 2005 Dec;37(6):560-3
16373238
Ann Thorac Surg. 1999 Nov;68(5):1863-5
10585082
Eur Respir J. 2001 Dec;18(6):1059-68
11829087
Cancer. 1994 Jun 1;73(11):2734-9
8194014